GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
Clinical trial NCT00358566 · TERMINATED
Trial details
- NCT number
- NCT00358566
- Sponsor
- Pharmexa A/S
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2008-08-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.